albendazole tablet buy Formulation and Performance Analysis-NEWS-Dingzhou Kangquan Pharmaceutical - Professional Veterinary Medicine Manufacturer

Introduction

Albendazole tablets are anthelmintic medications used in both human and veterinary medicine to treat a wide spectrum of parasitic worm infections. Their position within the pharmaceutical supply chain is as a finished dosage form, requiring stringent quality control and adherence to pharmacopoeial standards. The core performance characteristics of albendazole revolve around its efficacy against nematodes, cestodes, and trematodes, bioavailability dependent on formulation, and its safety profile determined by dosage and patient-specific factors. Understanding the physicochemical properties of albendazole, its manufacturing processes, and potential degradation pathways is crucial for ensuring product quality and clinical effectiveness. Formulation challenges often center on the drug's low aqueous solubility, impacting absorption and necessitating strategies for bioavailability enhancement. The increasing prevalence of anthelmintic resistance represents a critical challenge demanding optimized therapeutic regimens and potential novel formulations.

Material Science & Manufacturing

Albendazole (methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate) is a benzimidazole derivative. The raw material itself is a white to off-white powder. Key physicochemical properties include a molecular weight of 265.3 g/mol, a melting point of 208-210°C, and extremely low aqueous solubility (approximately 0.06 mg/mL at 25°C). This low solubility dictates specific formulation approaches. Manufacturing typically involves several stages: chemical synthesis of the albendazole active pharmaceutical ingredient (API), micronization to reduce particle size and increase surface area, blending with excipients (diluents, binders, disintegrants, lubricants), granulation (wet or dry), tableting, and coating. Critical parameters during granulation include binder concentration, mixing time, and moisture content, directly impacting granule size distribution and tablet compressibility. Tablet coating, often with a film coating, aims to improve palatability, protect the drug from environmental degradation, and modify drug release characteristics. Excipient compatibility studies are crucial; incompatibility can lead to drug degradation or altered dissolution profiles. Polymorphism, although less pronounced with albendazole than some APIs, must be considered during process development, as different polymorphs can exhibit variations in solubility and stability. Process Analytical Technology (PAT) is increasingly utilized for real-time monitoring and control of critical process parameters, ensuring consistent product quality.

Performance & Engineering

The therapeutic efficacy of albendazole is directly linked to its bioavailability. Due to its low solubility, absorption is often incomplete and variable. Formulation strategies, such as micronization, solid dispersions, and the inclusion of solubilizers, are employed to enhance dissolution and absorption. Bioavailability is further affected by food intake; administration with a fatty meal can significantly increase absorption. Albendazole's mechanism of action involves binding to beta-tubulin in parasitic worms, inhibiting microtubule polymerization and disrupting cellular processes essential for their survival. Engineering considerations include ensuring uniform drug distribution within the tablet matrix to guarantee dose uniformity. Environmental resistance is important, particularly regarding humidity. Albendazole is susceptible to degradation via oxidation and hydrolysis, necessitating packaging that provides a moisture barrier. Compliance requirements are dictated by regulatory agencies such as the FDA (US), EMA (Europe), and various national pharmacopoeias. Stability studies, conducted under accelerated and long-term conditions, are essential to establish shelf life and appropriate storage conditions. Pharmacokinetic/pharmacodynamic (PK/PD) modeling is used to optimize dosing regimens and predict therapeutic outcomes.

Technical Specifications

Parameter	Specification (USP/BP)	Testing Method	Acceptance Criteria
Assay (Albendazole content)	98.0% - 102.0%	HPLC	Complies
Identification	Positive	IR Spectroscopy	Complies
Related Substances	Individual: NMT 0.2% Total: NMT 0.5%	HPLC	Complies
Loss on Drying	NMT 0.5%	Gravimetric	Complies
Dissolution (Stage 1)	≥ 75% in 30 minutes	USP Apparatus 2	Complies
Particle Size (D90)	≤ 10 μm	Laser Diffraction	Complies

Failure Mode & Maintenance

Common failure modes for albendazole tablets include tablet friability (due to insufficient binder), capping or lamination (caused by air entrapment during compression or inadequate lubrication), and sticking to punches (resulting from excessive moisture or insufficient lubricant). Degradation is a significant concern. Hydrolysis can lead to the formation of albendazole sulfoxide, a less active metabolite. Oxidation, accelerated by light and heat, can also contribute to degradation. Physical instability, such as polymorphic conversion, is less frequent but possible. Maintenance strategies include proper storage conditions (cool, dry place protected from light), regular monitoring of environmental conditions in storage facilities, and adherence to first-expired, first-out (FEFO) inventory management principles. Quality control testing at each stage of manufacturing and periodically during shelf life is critical to detect degradation products and ensure product quality. Packaging should utilize moisture-resistant materials (e.g., aluminum blister packs) and provide protection from light. Complaint handling procedures should be in place to investigate and address any reported quality issues. Periodic validation of analytical methods is essential to maintain their accuracy and reliability.

Industry FAQ

Q: What is the impact of particle size distribution on albendazole tablet dissolution?

A: A narrower particle size distribution, with a smaller D90 value, generally leads to faster dissolution rates. Smaller particles have a larger surface area exposed to the dissolution medium, facilitating drug release. Micronization is employed to reduce particle size and enhance dissolution, especially given albendazole's inherent low solubility.

Q: How does humidity affect the stability of albendazole tablets?

A: High humidity can promote hydrolysis of albendazole, leading to the formation of degradation products. Proper packaging with moisture-resistant materials, such as aluminum blister packs, is essential to protect the tablets from moisture ingress. Storage in a controlled environment with low humidity is also crucial.

Q: What excipients are commonly used in albendazole tablet formulations and what role do they play?

A: Common excipients include microcrystalline cellulose (diluent/binder), croscarmellose sodium (disintegrant), magnesium stearate (lubricant), and colloidal silicon dioxide (glidant). The choice of excipients is critical to ensure good tablet compressibility, disintegration, and flowability. Solubilizers, like sodium lauryl sulfate, may also be incorporated to enhance dissolution.

Q: What analytical methods are used to ensure the quality of albendazole tablets?

A: Key analytical methods include High-Performance Liquid Chromatography (HPLC) for assay and related substances determination, Infrared (IR) Spectroscopy for identification, Karl Fischer titration for water content, and dissolution testing using USP Apparatus 2. Particle size analysis is performed using laser diffraction.

Q: What regulatory requirements must be met for manufacturing and marketing albendazole tablets?

A: Manufacturing must comply with Good Manufacturing Practices (GMP) regulations as outlined by agencies like the FDA (US) and EMA (Europe). Marketing authorization requires comprehensive documentation, including proof of efficacy, safety, and quality, as well as detailed manufacturing and control information. Adherence to pharmacopoeial standards (USP, BP, EP) is also mandatory.

Conclusion

Albendazole tablet manufacturing necessitates a thorough understanding of its physicochemical properties, particularly its low solubility, and the potential for degradation. Robust formulation strategies, coupled with stringent process control and quality assurance measures, are paramount to ensure product efficacy and patient safety. Optimizing the manufacturing process with techniques like PAT and employing appropriate packaging materials are critical steps.

Future advancements may focus on developing novel formulations, such as nanosuspensions or solid lipid nanoparticles, to further enhance bioavailability and overcome issues of anthelmintic resistance. Continuous monitoring of evolving regulatory requirements and implementing proactive quality management systems will be crucial for maintaining compliance and ensuring the continued availability of this essential medication.

Apr . 01, 2024 17:55 Back to list

albendazole tablet buy Formulation and Performance Analysis